Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects
NCT00981968
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Sitaxentan sodium/Placebo
DRUG:
Sitaxentan sodium/Placebo
Sponsor
Pfizer